Company Performance: Sanofi's financial results, including revenue, earnings, and profitability, significantly impact its stock price. Strong performance typically leads to investor confidence and higher stock valuation.

Drug Pipeline: Success or failure in developing and launching new drugs is critical. Positive clinical trial results and regulatory approvals drive the stock up, while setbacks can cause it to fall.

Market Conditions: Overall economic conditions and investor sentiment toward the pharmaceutical industry affect Sanofi's stock. Bull markets tend to lift all stocks, while bear markets can drag them down.

Regulatory Changes: Government regulations regarding drug pricing, approvals, and patents influence Sanofi's profitability and therefore its stock price. Stricter regulations can negatively impact the stock.

Competition: The competitive landscape, including the emergence of new drugs from competitors, affects Sanofi's market share and pricing power. Intense competition can put downward pressure on the stock.

Global Health Events: Pandemics or major disease outbreaks can significantly impact demand for certain Sanofi products, thereby affecting the stock price.

Dividend Policy: Sanofi's dividend policy can attract or deter investors. Consistent and growing dividends are generally viewed favorably, boosting the stock price.

Currency Fluctuations: As a global company, Sanofi's earnings are affected by currency exchange rates, which can impact the stock price, especially for NSE investors.

Investor Sentiment: General investor perception and media coverage influence demand for Sanofi's stock. Positive news and sentiment often lead to higher prices.